Dermata Therapeutics announces $3.4 million private placement
The San Diego dermatology company said insiders including its CEO and CFO are participating in the at-the-market priced deal, set to close August 18, 2026.
SEC filing
Latest
2 stories
Monday, August 17
Tuesday, August 11
Dermata sets August 25 launch for Tome skincare product, reports Q2 2026 results
Dermata Therapeutics said its first direct-to-consumer skincare product, Tome Foundational Treatment, is set to launch on August 25, 2026, as it reported second-quarter financials.
SEC filing